Comments
Sun Pharmaceutical Industries on Wednesday said its unit has received US health regulator’s approval for generic docetaxel injection, used in treating cancer, in the American market.
The company’s subsidiary - Sun Pharma Advanced Research Company - has received abbreviated new drug approval from US Food and Drug Administration for Docefrez in strength of 20 mg/vial and 80 mg/vial, Sun Pharma said in a statement.
The company’s product is indicated for metastatic breast cancer, lung cancer and hormone refractory metastatic prostate cancer, it added.
Shares of Sun Pharma were today trading at Rs 443 on the Bombay Stock Exchange in late afternoon trade, down 1.14 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.